Donna Lynn Dyess

2.3k citations
50 papers · 1.1k indexed · h-index 20

Donna Lynn Dyess

49 papers receiving 1.1k citations

Peers

Donna Lynn Dyess
Comparison fields: 5 of 105
  • Cancer Research 223
  • Oncology 301
  • Dermatology 83
  • Critical Care and Intensive Care Medicine 43
  • Rehabilitation 49
Replace Andrew J. Dalley with:
Andrew J. Dalley Australia
Manuel Salzmann Austria
Jiqiao Yang China
T. Hendriks Netherlands
Carlo Umberto Casciani Italy
Koji Naruishi Japan
Mitsunori Ikeda Japan
Yingan Jiang China
Artur Słomka Poland
Takashige Maeyama Japan
Donna Lynn Dyess relative to Andrew J. Dalley Australia Andrew J. Dalley's profile →
Citations per field
00.5×1.5×
Andrew J. Dalley · 1×
Citations per year

Countries citing papers authored by Donna Lynn Dyess

Since Specialization
Citations

This map shows the geographic impact of Donna Lynn Dyess's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna Lynn Dyess with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna Lynn Dyess more than expected).

Fields of papers citing papers by Donna Lynn Dyess

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna Lynn Dyess. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna Lynn Dyess. The network helps show where Donna Lynn Dyess may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Donna Lynn Dyess, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Donna Lynn Dyess Line = papers co-authored together Donna Lynn Dyess links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20247
2 202059
3 201740
4 20176
5 201460
6 201229
7 20109
8 200611
9 200511
10 200421
11 199927
12
Human breast carcinoma patients develop clonable oncofetal antigen-specific effector and regulatory T lymphocytes.
199929
13 199924
14 199412
15 19947
16 19925
17 199117
18 199123
19 19905
20 198818

About Donna Lynn Dyess

Donna Lynn Dyess is a scholar working on Cancer Research, Rehabilitation and Occupational Therapy, having authored 50 papers that have together received 1.1k indexed citations. Recurring topics across this work include Burn Injury Management and Outcomes (7 papers), Breast Cancer Treatment Studies (7 papers), Wound Healing and Treatments (5 papers), MicroRNA in disease regulation (5 papers), Infant Nutrition and Health (4 papers), Cancer and Skin Lesions (4 papers), Breast Lesions and Carcinomas (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). The work is most often cited by research in Cancer Research (223 citations), Oncology (301 citations) and Dermatology (83 citations). Donna Lynn Dyess has collaborated with scholars based in United States, Sweden and China. Frequent co-authors include John J. Ferrara, Ajay P. Singh, Seema Singh, Sachin Kumar Deshmukh, Sanjeev K. Srivastava, Rajeev S. Samant, Lalita A. Shevde, J. Allan Tucker, James E. Carter and Nikhil Tyagi. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Immunology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026